Sophia GeneticsFRA:90B +6.61%72 Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates FRA:90B with a GF Score™ of 72/100 and a GF Value™ of €4.27 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Sophia Genetics ranks worse than 355871.53% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Sophia Genetics is 0.00%.
The historical rank and industry rank for Sophia Genetics's Dividend Yield % or its related term are showing as below:
FRA:90B's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.4 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Sophia Genetics's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:90B vs SLP, TBRG, CARL: Dividend Yield % Comparison
For the Health Information Services subindustry, Sophia Genetics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sophia Genetics Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sophia Genetics's Dividend Yield % falls into.
Sophia Genetics (FRA:90B) has a Dividend Yield % of 0.00% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sophia Genetics and its competitors. According to the industry distribution chart, Sophia Genetics ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is Sophia Genetics' Dividend Yield % too high?
Sophia Genetics' current Dividend Yield % is 0.00%. Based on the distribution chart, Sophia Genetics ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Sophia Genetics has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Dividend Yield % compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Sophia Genetics ranks #999999 out of 281 companies for Dividend Yield %. This places Sophia Genetics in the lower half of its industry. The industry median Dividend Yield % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sophia Genetics and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sophia Genetics's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (FRA:90B) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.27, compared to a current price of €4.84 — trading 13.3% above its estimated fair value. The current Dividend Yield % is 0.00%. Sophia Genetics' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sophia Genetics (FRA:90B), the current Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sophia Genetics (FRA:90B) Overvalued in 2026?
Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued.
The current stock price of €4.84 is trading 13.3% above its estimated GF Value™ of €4.27.
GuruFocus considers Sophia Genetics to be Modestly Overvalued.
Key valuation signals for FRA:90B:
Dividend Yield %: 0.00%
GF Value™: €4.27 vs. price of €4.84 (13.3% above fair value)
No single metric tells the full story. See the FRA:90B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
72GF Score
Get the complete analysis for FRA:90B
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:90B has been successfully added to your 
